73 related articles for article (PubMed ID: 22213819)
21. Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.
Doot RK; McDonald ES; Mankoff DA
Clin Transl Imaging; 2014 Aug; 2(4):295-303. PubMed ID: 25229053
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.
Picchio M; Kirienko M; Mapelli P; Dell'Oca I; Villa E; Gallivanone F; Gianolli L; Messa C; Castiglioni I
Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):21-31. PubMed ID: 23990143
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of volume-based PET parameters in cancer patients.
Moon SH; Hyun SH; Choi JY
Korean J Radiol; 2013; 14(1):1-12. PubMed ID: 23323025
[TBL] [Abstract][Full Text] [Related]
24. Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.
Hatt M; van Stiphout R; le Pogam A; Lammering G; Visvikis D; Lambin P
Acta Oncol; 2013 Apr; 52(3):619-26. PubMed ID: 22873767
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.
Pan L; Gu P; Huang G; Xue H; Wu S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1008-15. PubMed ID: 19352191
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.
Omloo JM; van Heijl M; Hoekstra OS; van Berge Henegouwen MI; van Lanschot JJ; Sloof GW
Ann Surg Oncol; 2011 Nov; 18(12):3338-52. PubMed ID: 21537872
[TBL] [Abstract][Full Text] [Related]
27. Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.
Hatt M; Le Pogam A; Visvikis D; Pradier O; Cheze Le Rest C
J Nucl Med; 2012 Jan; 53(1):12-20. PubMed ID: 22213819
[TBL] [Abstract][Full Text] [Related]
28. Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
Woff E; Hendlisz A; Ameye L; Garcia C; Kamoun T; Guiot T; Paesmans M; Flamen P
J Nucl Med; 2019 Feb; 60(2):178-184. PubMed ID: 29959212
[TBL] [Abstract][Full Text] [Related]
29. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
[TBL] [Abstract][Full Text] [Related]
30. Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer.
Hatt M; Visvikis D; Pradier O; Cheze-le Rest C
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1595-606. PubMed ID: 21559979
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.
Hatt M; Visvikis D; Albarghach NM; Tixier F; Pradier O; Cheze-le Rest C
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1191-202. PubMed ID: 21365252
[TBL] [Abstract][Full Text] [Related]
32. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Tixier F; Le Rest CC; Hatt M; Albarghach N; Pradier O; Metges JP; Corcos L; Visvikis D
J Nucl Med; 2011 Mar; 52(3):369-78. PubMed ID: 21321270
[TBL] [Abstract][Full Text] [Related]
33. PET functional volume delineation: a robustness and repeatability study.
Hatt M; Cheze Le Rest C; Albarghach N; Pradier O; Visvikis D
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):663-72. PubMed ID: 21225425
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
